Press release
Biliary Atresia Market to Witness an Upsurge in Growth by 2034, Examines DelveInsight
Key Takeaways from the Biliary Atresia Market Research Report
* The increase in Biliary Atresia Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
* As per DelveInsight analysis, the Biliary Atresia Market is anticipated to witness growth at a considerable CAGR.
* The leading Biliary Atresia Companies working in the market include Mirium Pharmaceuticals, Albireo, Intercept Pharmaceuticals, and others.
* Promising Biliary Atresia Therapies in the various stages of development include BYLVAY, LIVMARLI, and others.
* March 2024:- Mirum Pharmaceuticals Inc.- Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of Maralixibat in the Treatment of Subjects With Biliary Atresia After Hepatoportoenterostomy. A study to evaluate the efficacy and safety of maralixibat in infants with Biliary Atresia (BA) after Hepatoportoenterostomy (HPE, also known as the Kasai procedure).
* March 2024: Albireo- An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat (A4250) in Children With Biliary Atresia (BOLD-EXT). This is a Phase 3, multi-center, open-label extension study to evaluate the long-term efficacy and safety of odevixibat in patients with Biliary Atresia (BA). Patients who completed treatment in the A4250-011 BOLD study and meet eligibility criteria for Study A4250-016 (BOLD-EXT) can participate. The duration of the treatment period is 104 weeks, followed by a 4-week Safety Follow-up Period. Patients who wish to continue receiving odevixibat after 104 weeks can remain on treatment in the optional extension period (OEP).
Discover which therapies are expected to grab the Biliary Atresia Market Share @ Biliary Atresia Market Outlook [https://www.delveinsight.com/sample-request/biliary-atresia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Biliary Atresia Overview
Biliary atresia is a rare liver disease that affects newborns. It occurs when the bile ducts, which carry bile from the liver to the gallbladder and small intestine, are either blocked or absent. This blockage prevents bile from flowing out of the liver, leading to a buildup of bile within the liver. Over time, this buildup damages the liver cells and can result in liver failure. Biliary atresia is typically diagnosed within the first few weeks or months of life and requires prompt medical intervention, often in the form of surgery to restore bile flow or a liver transplant. It is a serious condition that requires lifelong management and monitoring.
Biliary Atresia Epidemiology Insights
The Biliary Atresia epidemiology covered in the report provides historical as well as forecasted Biliary Atresia epidemiology [ segmented as Incident cases of Biliary Atresia, Type-specific Incident Cases of Biliary Atresia, Gender-specific Incident Cases of Biliary Atresia, and Treatable Cases of Biliary Atresia in the 7MM covering the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan from 2019 to 2032.
Download the report to understand which factors are driving Biliary Atresia Epidemiology trends @ Biliary Atresia Epidemiological Insights [https://www.delveinsight.com/sample-request/biliary-atresia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Biliary Atresia Drugs Market
The Biliary Atresia Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Biliary Atresia signaling in Biliary Atresia are likely to uncover new therapeutic targets and further expand treatment options for patients.
Biliary Atresia Treatment Market Landscape
The Biliary Atresia treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Biliary Atresia has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To learn more about Biliary Atresia treatment guidelines, visit @ Biliary Atresia Treatment Market Landscape [https://www.delveinsight.com/sample-request/biliary-atresia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Biliary Atresia Market Outlook
The report's outlook on the Biliary Atresia market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Biliary Atresia therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Biliary Atresia drug and late-stage pipeline therapy. It assesses their impact based on various factors such as annual therapy costs, inclusion/exclusion criteria, mechanism of action, compliance rates, market demand, patient population growth, covered patient segments, anticipated launch year, competition with other therapies, brand value, and input from key opinion leaders. The analyzed Biliary Atresia market data are presented concisely through relevant tables and graphs to offer a clear overview of the market dynamics.
Biliary Atresia Drugs Uptake
The drug chapter of the Biliary Atresia report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Biliary Atresia.
Major Biliary Atresia Companies
Mirium Pharmaceuticals, Albireo, Intercept Pharmaceuticals, and others.
Learn more about the FDA-approved drugs for Biliary Atresia @ Drugs for Biliary Atresia Treatment [https://www.delveinsight.com/sample-request/biliary-atresia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Biliary Atresia Market Report
* Coverage- 7MM
* Biliary Atresia Companies- Mirium Pharmaceuticals, Albireo, Intercept Pharmaceuticals, and others.
* Biliary Atresia Therapies- BYLVAY, LIVMARLI, and others.
* Biliary Atresia Market Dynamics: Biliary Atresia Market Drivers and Barriers
* Biliary Atresia Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about Biliary Atresia Drugs in development @ Biliary Atresia Clinical Trials Assessment [https://www.delveinsight.com/sample-request/biliary-atresia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
1. Key Insights
2. Biliary Atresia Executive Summary
3. Competitive Intelligence Analysis for Biliary Atresia
4. Biliary Atresia: Market Overview at a Glance
5. Biliary Atresia: Disease Background and Overview
6. Patient Journey
7. Biliary Atresia Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Biliary Atresia Unmet Needs
10. Key Endpoints of Biliary Atresia Treatment
11. Biliary Atresia Marketed Products
12. Biliary Atresia Emerging Therapies
13. Biliary Atresia: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Biliary Atresia Market Outlook
16. Biliary Atresia Market Access and Reimbursement Overview
17. Biliary Atresia KOL Views
18. Biliary Atresia Market Drivers
19. Biliary Atresia Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=biliary-atresia-market-to-witness-an-upsurge-in-growth-by-2034-examines-delveinsight]
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biliary Atresia Market to Witness an Upsurge in Growth by 2034, Examines DelveInsight here
News-ID: 3475564 • Views: …
More Releases from ABNewswire
98% Consistency, 0 Staff: Anno Robot Redefines Airport Coffee in 60 Countries
As millions of travellers rush through terminals worldwide, one constant complaint has finally been solved: bad airport coffee served slowly by exhausted staff. Shenzhen-based Anno Robot [https://www.coffeerobotsanno.com/] has quietly eliminated both problems with fully robotic kiosks that deliver 98% brew-to-brew consistency and require zero human baristas. By November 2025, these AI-powered stations are operating in airports and high-traffic hubs across more than 60 countries, marking a turning point for the…
FAXVIN Unveils Enhanced CarRank, a 0-100 Single-Score Summary That Makes Used-Ca …
Updated methodology brings additional partner data and refined signal weighting so shoppers and dealers can rank and compare vehicles in seconds.
WALNUT, Calif. - Nov. 19, 2025 - FAXVIN today announced a significant update to CarRank, its 0-100 vehicle-history metric designed to help shoppers and dealers compare used cars at a glance. The latest release incorporates additional data sources and methodology refinements that improve how risk signals are weighted across title…
Global Pro AV Market Surges Toward USD 127.31 Billion by 2030, Led by Sony, Sams …
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2025-2030.
According to Arizton research, the global pro AV market [https://www.arizton.com/market-reports/pro-av-market] was valued at USD 90.00 billion in 2024 and is projected to reach USD 127.31 billion by 2030, growing at a CAGR of 5.95% during the forecast period.
Explore the Full Market Insights: https://www.arizton.com/market-reports/pro-av-market
Report Summary:
Market Size (2030): USD 127.31 Billion
Market Size (2024): USD 90.00 Billion
CAGR (2024-2030): 5.95%
Historic…
Redway Power Launches High-Capacity 51.2V 420Ah Lithium Forklift Battery for Nex …
Redway Power, a leading OEM lithium battery manufacturer, proudly announces the launch of its latest innovation: the 51.2V 420Ah Lithium Forklift Battery [https://www.redwaypower.com/product/48v-420ah-forklift-lithium-battery/]. Designed for modern industrial operations, this next-generation battery combines high capacity, advanced safety features, and customizable OEM/ODM solutions to revolutionize warehouse productivity and material handling efficiency.
Introducing Next-Generation Power for Forklifts
The new 51.2V 420Ah battery is engineered to deliver exceptional energy efficiency and durability. With a nominal energy…
More Releases for Biliary
Global Metal Pancreatic Biliary Stent Market Size by Application, Type, and Geog …
According to Market Research Intellect, the global Metal Pancreatic Biliary Stent market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The metal pancreatic biliary stent market is witnessing consistent growth due to the rising prevalence of…
Major Market Share Shift in Biliary Catheters Industry: Advancements In Biliary …
What Is the Forecasted Market Size and Growth Rate for the Biliary Catheters Market?
The market size for biliary catheters has experienced robust growth in recent years. There is an expected growth from $3.42 billion in 2024 to $3.75 billion in 2025, corresponding to a compound annual growth rate (CAGR) of 9.7%. Factors like increased occurrences of biliary tract ailments, the popularity of minimally invasive procedures, a growing aging population, more…
Primary Biliary Cholangitis Treatment Market
Primary Biliary Cholangitis Treatment Market
Global Primary Biliary Cholangitis Treatment Market Expected to Reach US$ YY Million by 2030, Growing at a CAGR of YY%: Market Insights and Dynamics
The Global Primary Biliary Cholangitis Treatment Market, which reached US$ YY billion in 2022, is anticipated to achieve US$ YY million by 2030, exhibiting a robust CAGR of YY% during the forecast period from 2024 to 2031.
Primary Biliary Cholangitis (PBC), formerly known as…
Biliary Stents Market - Unleashing Flow: Empowering Biliary Health with Innovati …
Newark, New Castle, USA - new report, titled Biliary Stents Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Biliary Stents market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Biliary Stents market. The report offers an overview of the market, which…
High Prevalence of Biliary Diseases Across the Globe is Driving the Biliary Sten …
Stent is referred as plastic or metal tube inserted in human body into lumen or duct to keep the passage open. Various types of stents such as expandable stents and simple plastic stents are used for various purposes. Different types of stents such as coronary, vascular, and biliary stents are employed for various purposes. ‘Biliary’ is referred to the bile duct, which is a long tube-like structure carrying bile fluid.…
Rise in Surgical Procedures of Biliary Diseases is Expected to Boost the Biliary …
Stent is referred as plastic or metal tube inserted in human body into lumen or duct to keep the passage open. Various types of stents such as expandable stents and simple plastic stents are used for various purposes. Different types of stents such as coronary, vascular, and biliary stents are employed for various purposes. ‘Biliary’ is referred to the bile duct, which is a long tube-like structure carrying bile fluid.…
